AstraZeneca Türkiye Ransomware Claim by N0n (Sep 2026)

Claim Summary

On or around September 18, 2026, a ransomware group calling itself “N0n” allegedly listed AstraZeneca Türkiye (astrazeneca.com.tr) on its dark web leak site. According to the threat actor, the claimed breach affects the pharmaceutical manufacturer’s Turkish operations and involves approximately 940 MB of data. The group claims to have exfiltrated “complete internal network-security configuration of all 3 sites,” including rule sets, device definitions, and remote-access mappings, alongside a purported 1.35 million connection records spanning M365/Intune, SAP Concur, a UniFi camera estate, and internal applications.

The actor further claims that all affected sites are “enforcing a total network blackout until settlement” and has posted an active deadline of September 21, 2026, 03:01 UTC. None of these assertions have been independently confirmed. This listing should be treated as an unverified claim until corroborated by the organization or a trusted third party.

Threat Actor Profile

N0n is a relatively obscure ransomware operation with no widely documented track record in public threat intelligence. As of this report, the group’s total known victim count is unknown, and there is no publicly available research detailing its tooling, initial access vectors, or post-exploitation behavior. No YARA rules, IOCs, or detection signatures specific to N0n have been published at the time of writing.

Because the group’s history and capabilities are undocumented, its credibility cannot be reliably assessed. Some low-profile actors exaggerate data volumes and operational impact to manufacture urgency. The absence of a verifiable leak sample, combined with the group’s thin public footprint, warrants heightened skepticism. Readers should avoid assuming the claim is either genuine or fabricated based on the leak site listing alone.

Alleged Data Exposure

The actor purports to hold 940 MB of data, which it characterizes as network-security configuration and connection logs rather than patient records or clinical trial data. The claimed categories include:

• Network security rule sets and device definitions across three sites
• Remote-access mappings
• Approximately 1.35 million connection records referencing M365/Intune, SAP Concur, a UniFi camera estate, and internal applications
• References to GxP (Good Manufacturing Practice) environments

If authentic, configuration and remote-access data could be sensitive, but the claim does not, on its face, describe direct exposure of personal health information. Yazoul Security has not reviewed, downloaded, or validated any of the alleged data, and no samples or access details are included here by policy.

Potential Impact

Should the claim prove accurate, the exposure of network configuration and remote-access mappings could theoretically aid follow-on intrusion or lateral movement if those credentials and paths remain valid. GxP environments carry regulatory weight in pharmaceutical manufacturing, so any confirmed tampering or downtime could trigger compliance scrutiny. The claimed “network blackout” - if real - could disrupt operations, though ransomware operators frequently overstate such effects to pressure victims.

At this stage, all impact statements are speculative. There is no confirmation of data authenticity, scope, or operational disruption.

What to Watch For

• Official statements from AstraZeneca or AstraZeneca Türkiye confirming or denying the claim
• Regulatory notifications from Turkish authorities or relevant healthcare and pharmaceutical regulators
• Publication of verifiable samples that would corroborate the actor’s claims
• Any extension, removal, or escalation of the posted deadline
• Independent research establishing N0n’s tactics, techniques, and procedures

Organizations in healthcare and pharmaceutical manufacturing should review remote-access configurations and network segmentation as a precaution, independent of this specific claim.

Disclaimer

This report is based solely on an unverified claim published on a ransomware group’s leak site. Yazoul Security has NOT independently verified the attack, the data, the volume, or the actor’s identity. Ransomware groups routinely exaggerate or fabricate claims to pressure victims. Nothing here should be treated as fact. No PII, credentials, samples, or access instructions are provided. For related analysis, see our /intel/ and /advisory/ sections.